Rankings
▼
Calendar
OABI (OmniAb, Inc.) Stock Financials & Earnings | Market Cap Arena
OABI
OmniAb, Inc.
Mkt Cap
$231M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$19M
Net Income (TTM)
-$65M
EPS (TTM)
-$0.57
Free Cash Flow (TTM)
-$37M
Gross Margin
73.5%
Op. Margin
-369.6%
Net Margin
-347.0%
FCF Margin
-198.3%
P/S Ratio (TTM)
12.4x
P/E Ratio (TTM)
—
YoY Rev Growth
-29.3%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$17M
$13M
-$8M
Q2 23
$7M
$2M
-$19M
Q3 23
$5M
$633K
-$20M
Q4 23
$5M
$5M
-$21M
Q1 24
$4M
$4M
-$23M
Q2 24
$8M
$8M
-$16M
Q3 24
$4M
$4M
-$20M
Q4 24
$11M
$11M
-$16M
Q1 25
$4M
$4M
-$19M
Q2 25
$4M
$4M
-$16M
Q3 25
$2M
-$2M
-$18M
Q4 25
$8M
$8M
-$16M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
3.5x
—
Q2 23
3.5x
—
Q3 23
3.6x
—
Q4 23
6.8x
—
Q1 24
11.0x
—
Q2 24
10.6x
—
Q3 24
11.3x
—
Q4 24
8.8x
—
Q1 25
8.6x
—
Q2 25
10.0x
—
Q3 25
11.0x
—
Q4 25
12.4x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$28M
$27M
Q2 23
-$10M
-$11M
Q3 23
-$6M
-$7M
Q4 23
-$9M
-$9M
Q1 24
-$17M
-$18M
Q2 24
-$12M
-$13M
Q3 24
-$7M
-$7M
Q4 24
-$4M
-$4M
Q1 25
-$16M
-$16M
Q2 25
-$5M
-$5M
Q3 25
-$10M
-$10M
Q4 25
-$6M
-$6M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$234K
Q2 23
$813K
Q3 23
$490K
Q4 23
$107K
Q1 24
$926K
Q2 24
$751K
Q3 24
$152K
Q4 24
$46K
Q1 25
$209K
Q2 25
$165K
Q3 25
$182K
Q4 25
$9K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+75.8%
+38.5%
Q2 23
-3.5%
+33.9%
Q3 23
-20.7%
+17.0%
Q4 23
-86.4%
-1.4%
Q1 24
-77.5%
+4.1%
Q2 24
+9.6%
-8.9%
Q3 24
-23.8%
-7.1%
Q4 24
+124.1%
+2.5%
Q1 25
+9.3%
-12.7%
Q2 25
-48.8%
-15.9%
Q3 25
-46.3%
-14.8%
Q4 25
-22.5%
-9.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$6M
35.8%
Q2 23
$7M
94.0%
Q3 23
$6M
115.2%
Q4 23
$6M
122.9%
Q1 24
$6M
149.8%
Q2 24
$5M
70.7%
Q3 24
$5M
127.2%
Q4 24
$5M
47.4%
Q1 25
$4M
99.8%
Q2 25
$4M
105.5%
Q3 25
$0
0.0%
Q4 25
$4M
43.1%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$14M
—
$7M
Q2 23
$14M
—
$7M
Q3 23
$14M
—
$7M
Q4 23
$15M
$8M
—
Q1 24
$15M
$8M
—
Q2 24
$14M
$8M
—
Q3 24
$13M
$7M
—
Q4 24
$13M
$7M
—
Q1 25
$13M
$8M
—
Q2 25
$11M
$8M
—
Q3 25
$10M
—
$5M
Q4 25
$14M
$7M
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$23M
$91M
$114M
Q2 23
$21M
$82M
$103M
Q3 23
$21M
$75M
$97M
Q4 23
$16M
$71M
$87M
Q1 24
$19M
$50M
$69M
Q2 24
$21M
$36M
$57M
Q3 24
$27M
$32M
$59M
Q4 24
$28M
$32M
$59M
Q1 25
$11M
$33M
$44M
Q2 25
$18M
$23M
$42M
Q3 25
$29M
$31M
$60M
Q4 25
$26M
$29M
$54M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
99M
+5.8%
Q2 23
99M
+0.3%
Q3 23
100M
+0.4%
Q4 23
100M
+0.3%
Q1 24
101M
+0.6%
Q2 24
101M
+0.7%
Q3 24
102M
+0.9%
Q4 24
105M
+2.3%
Q1 25
106M
+0.8%
Q2 25
106M
+0.5%
Q3 25
115M
+8.1%
Q4 25
128M
+11.4%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 19
—
—
FY 20
—
—
FY 21
$5M
7
FY 22
$622K
95
FY 23
$322K
106
FY 24
$232K
114
FY 25
$210K
89
marketcaparena.com